Skip to main content
. 2020 Jul 17;25(11):1881–1891. doi: 10.1007/s10147-020-01747-1

Fig. 3.

Fig. 3

Forest and funnel plots showing the association of serum testosterone levels with oncological outcomes in patients with castration-resistant prostate cancer treated with androgen receptor-targeted agents; a overall survival, b progression-free survival